| Company Name: |
Energy Chemical |
| Tel: |
400-0056266 18918157536; |
| Email: |
sales8178@energy-chemical.com |
| Company Name: |
LGM Pharma |
| Tel: |
1-(800)-881-8210 |
| Email: |
inquiries@lgmpharma.com |
- Tylosin tartrate
-
-
2026-10-16
- CAS:74610-55-2
- Min. Order: 25KG
- Purity: ≥900μ/mg; EP9.0
- Supply Ability: 20tons/month
- Tylosin Tartrate
-
-
2026-10-14
- CAS:74610-55-2
- Min. Order: 1g
- Purity: 98% HPLC
- Supply Ability: 100kgs
- Tylosin tartrate
-
- $39.00
-
2026-07-15
- CAS:74610-55-2
- Purity: 99.36%
- Supply Ability: 10g
|
| | Tylosin tartrate Basic information |
| | Tylosin tartrate Chemical Properties |
| Melting point | 140-146 °C | | storage temp. | Inert atmosphere,Store in freezer, under -20°C | | solubility | H2O: 50 mg/mL, clear, yellow-green | | form | powder | | color | colorless to yellow | | InChIKey | TYMALGUEUDCGQA-ULWJMSOTSA-N |
| | Tylosin tartrate Usage And Synthesis |
| Chemical Properties | Light yellow powder | | Uses | Tylosin Tartrate is a macrolide antibiotic isolated from a strain of Streptomycetes fradiae found in soil from Thailand. Antibacterial. | | Uses | Tylosin tartrate is used as chemotherapeutic agent used to treat pigs with enteritis, household pets with respiratory infections and mastitis in cows. | | Uses | Tylosin tartrate is a macrolide antibiotic approved for the control of mycoplasmosis in poultry | | in vivo | Tylosin tartrate (10-500 mg/kg; s.c.) generally suppresses the elevated TNF-α and IL-1β levels and increases the IL-10 levels in the Lipopolysaccharide (LPS) -treated animals[4].
| Animal Model: | Balb/C mice (2-3 months old, 20-25 g)[4] | | Dosage: | 10 mg/kg, 100 mg/kg, 500 mg/kg | | Administration: | Subcutaneous injection | | Result: | Reduced the elevated TNF-α and IL-1β in LPS (250 μg)-treated mice but increased their IL-10 levels. |
| | IC 50 | Macrolide |
| | Tylosin tartrate Preparation Products And Raw materials |
|